Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancer. | Res Sq | 2023 | 37398210 | PubTator, text mining | PubMed |
| DNA-PK is activated by SIRT2 deacetylation to promote DNA double-strand break repair by non-homologous end joining. | Nucleic Acids Res | 2023 | 37395399 | PubTator, text mining | PubMed |
| Repair of topoisomerase 1-induced DNA damage by tyrosyl-DNA phosphodiesterase 2 (TDP2) is dependent on its magnesium binding. | J Biol Chem | 2023 | 37392847 | PubTator, text mining | PubMed |
| Severe Combined Immunodeficiency-Classification, Microbiology Association and Treatment. | Microorganisms | 2023 | 37375091 | PubTator, text mining | PubMed |
| Non-Homologous End-Joining Pathway Genotypes Significantly Associated with Nasopharyngeal Carcinoma Susceptibility. | Biomedicines | 2023 | 37371742 | PubTator, text mining | PubMed |
| The HIV-1 capsid core is an opportunistic nuclear import receptor. | Nat Commun | 2023 | 37355754 | PubTator, text mining | PubMed |
| Quantitative profiling of genes associated with cancer pathways in brain tumors. | Klin Onkol | 2023 | 37353350 | PubTator, text mining | PubMed |
| Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies. | Cancers (Basel) | 2023 | 37345145 | PubTator, text mining | PubMed |
| WNT-Conditioned Mechanism of Exit from Postchemotherapy Shock of Differentiated Tumour Cells. | Cancers (Basel) | 2023 | 37345102 | PubTator, text mining | PubMed |
| Systematic analysis of the molecular and biophysical properties of key DNA damage response factors. | Elife | 2023 | 37341699 | PubTator, text mining | PubMed |
| Plant PAXX has an XLF-like function and stimulates DNA end joining by the Ku-DNA ligase IV/XRCC4 complex. | Plant J | 2023 | 37340932 | PubTator, text mining | PubMed |
| Admixture mapping implicates 13q33.3 as ancestry-of-origin locus for Alzheimer disease in Hispanic and Latino populations. | HGG Adv | 2023 | 37333771 | PubTator, text mining | PubMed |
| Molecular mechanisms of tumor resistance to radiotherapy. | Mol Cancer | 2023 | 37322433 | PubTator, text mining | PubMed |
| Mitotic tethering enables inheritance of shattered micronuclear chromosomes. | Nature | 2023 | 37316668 | PubTator, text mining | PubMed |
| SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity. | Sci Adv | 2023 | 37315132 | PubTator, text mining | PubMed |
| Cryo-EM structure of a DNA-PK trimer: higher order oligomerisation in NHEJ. | Structure | 2023 | 37311458 | PubTator, text mining | PubMed |
| ATM phosphorylates the FATC domain of DNA-PKcs at threonine 4102 to promote non-homologous end joining. | Nucleic Acids Res | 2023 | 37309889 | PubTator, text mining | PubMed |
| Phosphorylation of DNA-PKcs at the S2056 cluster ensures efficient and productive lymphocyte development in XLF-deficient mice. | Proc Natl Acad Sci U S A | 2023 | 37307443 | PubTator, text mining | PubMed |
| The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer. | Front Cell Dev Biol | 2023 | 37305685 | PubTator, text mining | PubMed |
| The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways. | Int J Mol Sci | 2023 | 37298600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=13